Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

2.

Patient monitoring: the hidden costs of treatment with antipsychotics.

Nederlof M, Frederix GW, Stoker LJ, van Solinge WW, Egberts TC, Heerdink ER.

Br J Clin Pharmacol. 2016 Aug;82(2):570-2. doi: 10.1111/bcp.12982. Epub 2016 May 31. No abstract available.

3.

Instructions for clinical and biomarker monitoring in the Summary of Product Characteristics (SmPC) for psychotropic drugs: Overview and applicability in clinical practice.

Nederlof M, Stoker LJ, Egberts TC, Heerdink ER.

J Psychopharmacol. 2015 Dec;29(12):1248-54. doi: 10.1177/0269881115609016. Epub 2015 Oct 13.

PMID:
26464457
4.

Medication Discontinuation in Patients After Discharge From a Psychiatric Hospital.

Abdullah-Koolmees H, Gardarsdottir H, Yazir D, Stoker LJ, Vuyk J, Egberts TC, Heerdink ER.

Ann Pharmacother. 2015 Oct;49(10):1085-95. doi: 10.1177/1060028015593763. Epub 2015 Jul 9.

PMID:
26160969
5.

Discontinuation of somatic medication during psychiatric hospitalization.

Abdullah-Koolmees H, Gardarsdottir H, Stoker LJ, Vuyk J, Egberts TC, Heerdink ER.

Ann Pharmacother. 2014 Nov;48(11):1415-24. doi: 10.1177/1060028014544897. Epub 2014 Jul 30.

PMID:
25078262
6.

Prevalence of medication use for somatic disease in institutionalized psychiatric patients.

Abdullah-Koolmees H, Gardarsdottir H, Stoker LJ, Vuyk J, Egberts TC, Heerdink ER.

Pharmacopsychiatry. 2013 Nov;46(7):274-80. doi: 10.1055/s-0033-1354405. Epub 2013 Oct 8.

PMID:
24105078
7.

Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: a double-blind randomized clinical trial.

Samim M, Twigt B, Stoker L, Pronk A.

Ann Surg. 2012 Jan;255(1):18-22. doi: 10.1097/SLA.0b013e318225178a.

PMID:
21685792
8.

Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study.

Leendertse AJ, Van Den Bemt PM, Poolman JB, Stoker LJ, Egberts AC, Postma MJ.

Value Health. 2011 Jan;14(1):34-40. doi: 10.1016/j.jval.2010.10.024.

9.

Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.

Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM; HARM Study Group.

Arch Intern Med. 2008 Sep 22;168(17):1890-6. doi: 10.1001/archinternmed.2008.3.

PMID:
18809816
10.

Geographical influences upon physical activity participation: evidence of a 'coastal effect'.

Bauman A, Smith B, Stoker L, Bellew B, Booth M.

Aust N Z J Public Health. 1999 Jun;23(3):322-4.

PMID:
10388181
11.

Discriminant attitudes and beliefs about condoms in young, multi-partner heterosexuals.

Chapman S, Stoker L, Ward M, Porritt D, Fahey P.

Int J STD AIDS. 1990 Nov;1(6):422-8.

PMID:
2094404
12.

Studies in the rat on bucindolol, a new antihypertensive agent with beta-adrenoceptor blocking properties.

Oates HF, Stoker LM, Stokes GS.

Arch Int Pharmacodyn Ther. 1981 May;251(1):95-102.

PMID:
6114719
13.

Studies in the rat on endralazine, a new antihypertensive drug structurally related to hydralazine.

Oates HF, Stoker LM.

Clin Exp Pharmacol Physiol. 1981 Mar-Apr;8(2):133-9.

PMID:
7018762
14.

Haemodynamic interactions between alpha- and beta-adrenoceptor antagonists in conscious or anaesthetized rats.

Oates HF, Stoker LM.

Clin Exp Pharmacol Physiol. 1980 Mar-Apr;7(2):231-6.

PMID:
6103770
15.

Profile of a new prazosin congener, BL-5111A. Studies in the rat.

Oates HF, Stoker LM, Stokes GS.

Clin Exp Pharmacol Physiol. 1980 Jan-Feb;7(1):1-9.

PMID:
7379338
16.

A new prazosin analogue BL-5111A.

Oates HF, Stoker LM.

Arch Int Pharmacodyn Ther. 1979 Aug;240(2):305-13. No abstract available.

PMID:
508011
17.

Effects of prazosin on blood pressure and plasma renin activity during onset and withdrawal of action in the anaesthetized rat.

Oates HF, Stoker LM, Monaghan JC.

Clin Exp Pharmacol Physiol. 1979 May-Jun;6(3):355-8.

PMID:
572749
18.

Studies in the rat on the haemodynamic overshoot response to withdrawal of guanfacine or clonidine treatment.

Oates HF, Stoker LM, Stokes GS.

Clin Exp Pharmacol Physiol. 1979 Jan-Feb;6(1):61-8.

PMID:
32983
19.

The beta-adrenoceptor controlling renin release.

Oates HF, Stoker LM, Monaghan JC, Stokes GS.

Arch Int Pharmacodyn Ther. 1978 Aug;234(2):205-13.

PMID:
213037
20.

Withdrawal of clonidine: effects of varying dosage or duration of treatment on subsequent blood pressure and heart rate responses.

Oates HF, Stoker LM, Monaghan JC, Stokes GS.

J Pharmacol Exp Ther. 1978 Aug;206(2):268-73.

PMID:
28415

Supplemental Content

Loading ...
Support Center